Cargando…
Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy
Nine pretreated patients aged >19 years with relapsed/refractory acute lymphoblastic leukemia (ALL) were treated with a combination of bortezomib plus chemotherapy before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Eight (88.9%) patients, including two Philadelphia chromosome-...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472074/ https://www.ncbi.nlm.nih.gov/pubmed/26109875 http://dx.doi.org/10.2147/IJGM.S59537 |